nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—Urate nephropathy—Vincristine—lymphatic system cancer	0.126	0.302	CcSEcCtD
Telaprevir—ABCB1—Mitoxantrone—lymphatic system cancer	0.103	0.177	CbGbCtD
Telaprevir—CYP3A4—Cytarabine—lymphatic system cancer	0.0896	0.154	CbGbCtD
Telaprevir—CYP3A4—Teniposide—lymphatic system cancer	0.0882	0.152	CbGbCtD
Telaprevir—ALB—Methotrexate—lymphatic system cancer	0.082	0.141	CbGbCtD
Telaprevir—ABCB1—Vincristine—lymphatic system cancer	0.0709	0.122	CbGbCtD
Telaprevir—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0617	0.106	CbGbCtD
Telaprevir—ABCB1—Methotrexate—lymphatic system cancer	0.0429	0.0739	CbGbCtD
Telaprevir—CYP3A4—Vincristine—lymphatic system cancer	0.0425	0.0731	CbGbCtD
Telaprevir—Lymphopenia—Mechlorethamine—lymphatic system cancer	0.0216	0.0515	CcSEcCtD
Telaprevir—Hyperuricaemia—Fludarabine—lymphatic system cancer	0.00772	0.0184	CcSEcCtD
Telaprevir—Blood uric acid increased—Fludarabine—lymphatic system cancer	0.00729	0.0174	CcSEcCtD
Telaprevir—Oral candidiasis—Carmustine—lymphatic system cancer	0.00722	0.0172	CcSEcCtD
Telaprevir—Retinal disorder—Methotrexate—lymphatic system cancer	0.00594	0.0142	CcSEcCtD
Telaprevir—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00525	0.0125	CcSEcCtD
Telaprevir—Hyperuricaemia—Vincristine—lymphatic system cancer	0.00472	0.0112	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.00468	0.0112	CcSEcCtD
Telaprevir—Hyperuricaemia—Mitoxantrone—lymphatic system cancer	0.00459	0.011	CcSEcCtD
Telaprevir—Blood uric acid increased—Vincristine—lymphatic system cancer	0.00446	0.0106	CcSEcCtD
Telaprevir—Candida infection—Carmustine—lymphatic system cancer	0.00438	0.0104	CcSEcCtD
Telaprevir—Blood uric acid increased—Mitoxantrone—lymphatic system cancer	0.00434	0.0103	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00409	0.00974	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00397	0.00947	CcSEcCtD
Telaprevir—Infection—Mechlorethamine—lymphatic system cancer	0.00392	0.00934	CcSEcCtD
Telaprevir—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00386	0.00921	CcSEcCtD
Telaprevir—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00383	0.00914	CcSEcCtD
Telaprevir—Erythema multiforme—Fludarabine—lymphatic system cancer	0.0034	0.00811	CcSEcCtD
Telaprevir—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.00335	0.00799	CcSEcCtD
Telaprevir—Anaemia—Teniposide—lymphatic system cancer	0.00329	0.00785	CcSEcCtD
Telaprevir—Malnutrition—Fludarabine—lymphatic system cancer	0.00313	0.00747	CcSEcCtD
Telaprevir—Hypokalaemia—Carmustine—lymphatic system cancer	0.00303	0.00722	CcSEcCtD
Telaprevir—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.0029	0.00691	CcSEcCtD
Telaprevir—Anaemia—Fludarabine—lymphatic system cancer	0.00289	0.0069	CcSEcCtD
Telaprevir—Infection—Teniposide—lymphatic system cancer	0.00289	0.00689	CcSEcCtD
Telaprevir—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00285	0.00679	CcSEcCtD
Telaprevir—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00282	0.00671	CcSEcCtD
Telaprevir—Pruritus—Mechlorethamine—lymphatic system cancer	0.00279	0.00665	CcSEcCtD
Telaprevir—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0027	0.00644	CcSEcCtD
Telaprevir—Infection—Fludarabine—lymphatic system cancer	0.00254	0.00605	CcSEcCtD
Telaprevir—Vomiting—Mechlorethamine—lymphatic system cancer	0.00251	0.00598	CcSEcCtD
Telaprevir—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00251	0.00598	CcSEcCtD
Telaprevir—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0025	0.00597	CcSEcCtD
Telaprevir—Rash—Mechlorethamine—lymphatic system cancer	0.00249	0.00593	CcSEcCtD
Telaprevir—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00248	0.00592	CcSEcCtD
Telaprevir—Nausea—Mechlorethamine—lymphatic system cancer	0.00234	0.00559	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Methotrexate—lymphatic system cancer	0.00233	0.00557	CcSEcCtD
Telaprevir—Urticaria—Teniposide—lymphatic system cancer	0.00231	0.00551	CcSEcCtD
Telaprevir—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.00229	0.00546	CcSEcCtD
Telaprevir—Oedema peripheral—Carmustine—lymphatic system cancer	0.00227	0.00541	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00221	0.00526	CcSEcCtD
Telaprevir—Fatigue—Fludarabine—lymphatic system cancer	0.0022	0.00525	CcSEcCtD
Telaprevir—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00217	0.00518	CcSEcCtD
Telaprevir—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.00216	0.00516	CcSEcCtD
Telaprevir—Urethral disorder—Vincristine—lymphatic system cancer	0.00215	0.00514	CcSEcCtD
Telaprevir—Eye disorder—Carmustine—lymphatic system cancer	0.00215	0.00513	CcSEcCtD
Telaprevir—Anaemia—Bleomycin—lymphatic system cancer	0.00212	0.00506	CcSEcCtD
Telaprevir—Asthenia—Teniposide—lymphatic system cancer	0.00209	0.00497	CcSEcCtD
Telaprevir—Pruritus—Teniposide—lymphatic system cancer	0.00206	0.00491	CcSEcCtD
Telaprevir—Malnutrition—Carmustine—lymphatic system cancer	0.002	0.00478	CcSEcCtD
Telaprevir—Diarrhoea—Teniposide—lymphatic system cancer	0.00199	0.00474	CcSEcCtD
Telaprevir—Infection—Bleomycin—lymphatic system cancer	0.00186	0.00444	CcSEcCtD
Telaprevir—Anaemia—Carmustine—lymphatic system cancer	0.00185	0.00442	CcSEcCtD
Telaprevir—Vomiting—Teniposide—lymphatic system cancer	0.00185	0.00441	CcSEcCtD
Telaprevir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00183	0.00437	CcSEcCtD
Telaprevir—Asthenia—Fludarabine—lymphatic system cancer	0.00183	0.00437	CcSEcCtD
Telaprevir—Rash—Teniposide—lymphatic system cancer	0.00183	0.00437	CcSEcCtD
Telaprevir—Dermatitis—Teniposide—lymphatic system cancer	0.00183	0.00437	CcSEcCtD
Telaprevir—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00182	0.00435	CcSEcCtD
Telaprevir—Pruritus—Fludarabine—lymphatic system cancer	0.00181	0.00431	CcSEcCtD
Telaprevir—Anaemia—Vincristine—lymphatic system cancer	0.00177	0.00422	CcSEcCtD
Telaprevir—Diarrhoea—Fludarabine—lymphatic system cancer	0.00175	0.00417	CcSEcCtD
Telaprevir—Nausea—Teniposide—lymphatic system cancer	0.00173	0.00412	CcSEcCtD
Telaprevir—Anaemia—Mitoxantrone—lymphatic system cancer	0.00172	0.00411	CcSEcCtD
Telaprevir—Renal failure acute—Methotrexate—lymphatic system cancer	0.00167	0.00398	CcSEcCtD
Telaprevir—Infection—Carmustine—lymphatic system cancer	0.00162	0.00387	CcSEcCtD
Telaprevir—Vomiting—Fludarabine—lymphatic system cancer	0.00162	0.00387	CcSEcCtD
Telaprevir—Rash—Fludarabine—lymphatic system cancer	0.00161	0.00384	CcSEcCtD
Telaprevir—Dermatitis—Fludarabine—lymphatic system cancer	0.00161	0.00384	CcSEcCtD
Telaprevir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.0016	0.00382	CcSEcCtD
Telaprevir—Infection—Vincristine—lymphatic system cancer	0.00155	0.0037	CcSEcCtD
Telaprevir—Nervous system disorder—Vincristine—lymphatic system cancer	0.00153	0.00365	CcSEcCtD
Telaprevir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00153	0.00365	CcSEcCtD
Telaprevir—Nausea—Fludarabine—lymphatic system cancer	0.00152	0.00362	CcSEcCtD
Telaprevir—Infection—Mitoxantrone—lymphatic system cancer	0.00151	0.0036	CcSEcCtD
Telaprevir—Shock—Mitoxantrone—lymphatic system cancer	0.0015	0.00357	CcSEcCtD
Telaprevir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00149	0.00355	CcSEcCtD
Telaprevir—Urticaria—Bleomycin—lymphatic system cancer	0.00149	0.00355	CcSEcCtD
Telaprevir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00148	0.00352	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00141	0.00337	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00139	0.00331	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00135	0.00321	CcSEcCtD
Telaprevir—Fatigue—Vincristine—lymphatic system cancer	0.00135	0.00321	CcSEcCtD
Telaprevir—Asthenia—Bleomycin—lymphatic system cancer	0.00134	0.00321	CcSEcCtD
Telaprevir—Pruritus—Bleomycin—lymphatic system cancer	0.00133	0.00316	CcSEcCtD
Telaprevir—Eosinophilia—Methotrexate—lymphatic system cancer	0.00132	0.00315	CcSEcCtD
Telaprevir—Fatigue—Mitoxantrone—lymphatic system cancer	0.00131	0.00313	CcSEcCtD
Telaprevir—Urticaria—Mitoxantrone—lymphatic system cancer	0.00121	0.00288	CcSEcCtD
Telaprevir—Vomiting—Bleomycin—lymphatic system cancer	0.00119	0.00284	CcSEcCtD
Telaprevir—Infestation NOS—Methotrexate—lymphatic system cancer	0.00119	0.00283	CcSEcCtD
Telaprevir—Infestation—Methotrexate—lymphatic system cancer	0.00119	0.00283	CcSEcCtD
Telaprevir—Rash—Bleomycin—lymphatic system cancer	0.00118	0.00282	CcSEcCtD
Telaprevir—Dermatitis—Bleomycin—lymphatic system cancer	0.00118	0.00281	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00118	0.00281	CcSEcCtD
Telaprevir—Asthenia—Carmustine—lymphatic system cancer	0.00117	0.0028	CcSEcCtD
Telaprevir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00112	0.00268	CcSEcCtD
Telaprevir—Asthenia—Vincristine—lymphatic system cancer	0.00112	0.00267	CcSEcCtD
Telaprevir—Diarrhoea—Carmustine—lymphatic system cancer	0.00112	0.00267	CcSEcCtD
Telaprevir—Nausea—Bleomycin—lymphatic system cancer	0.00111	0.00265	CcSEcCtD
Telaprevir—Asthenia—Mitoxantrone—lymphatic system cancer	0.00109	0.0026	CcSEcCtD
Telaprevir—Dizziness—Carmustine—lymphatic system cancer	0.00108	0.00258	CcSEcCtD
Telaprevir—Diarrhoea—Vincristine—lymphatic system cancer	0.00107	0.00255	CcSEcCtD
Telaprevir—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00105	0.00251	CcSEcCtD
Telaprevir—Urethral disorder—Methotrexate—lymphatic system cancer	0.00105	0.00249	CcSEcCtD
Telaprevir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00104	0.00248	CcSEcCtD
Telaprevir—Vomiting—Carmustine—lymphatic system cancer	0.00104	0.00248	CcSEcCtD
Telaprevir—Dizziness—Vincristine—lymphatic system cancer	0.00103	0.00246	CcSEcCtD
Telaprevir—Rash—Carmustine—lymphatic system cancer	0.00103	0.00246	CcSEcCtD
Telaprevir—Dermatitis—Carmustine—lymphatic system cancer	0.00103	0.00246	CcSEcCtD
Telaprevir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00101	0.0024	CcSEcCtD
Telaprevir—Eye disorder—Methotrexate—lymphatic system cancer	0.000996	0.00238	CcSEcCtD
Telaprevir—Vomiting—Vincristine—lymphatic system cancer	0.000993	0.00237	CcSEcCtD
Telaprevir—Rash—Vincristine—lymphatic system cancer	0.000984	0.00235	CcSEcCtD
Telaprevir—Dermatitis—Vincristine—lymphatic system cancer	0.000983	0.00235	CcSEcCtD
Telaprevir—Nausea—Carmustine—lymphatic system cancer	0.000971	0.00232	CcSEcCtD
Telaprevir—Vomiting—Mitoxantrone—lymphatic system cancer	0.000967	0.00231	CcSEcCtD
Telaprevir—Rash—Mitoxantrone—lymphatic system cancer	0.000959	0.00229	CcSEcCtD
Telaprevir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000958	0.00228	CcSEcCtD
Telaprevir—Malnutrition—Methotrexate—lymphatic system cancer	0.000928	0.00221	CcSEcCtD
Telaprevir—Nausea—Vincristine—lymphatic system cancer	0.000927	0.00221	CcSEcCtD
Telaprevir—Dysgeusia—Methotrexate—lymphatic system cancer	0.000909	0.00217	CcSEcCtD
Telaprevir—Nausea—Mitoxantrone—lymphatic system cancer	0.000903	0.00215	CcSEcCtD
Telaprevir—Anaemia—Methotrexate—lymphatic system cancer	0.000858	0.00205	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000785	0.00187	CcSEcCtD
Telaprevir—Infection—Methotrexate—lymphatic system cancer	0.000753	0.00179	CcSEcCtD
Telaprevir—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000743	0.00177	CcSEcCtD
Telaprevir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000742	0.00177	CcSEcCtD
Telaprevir—Skin disorder—Methotrexate—lymphatic system cancer	0.000736	0.00175	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000654	0.00156	CcSEcCtD
Telaprevir—Fatigue—Methotrexate—lymphatic system cancer	0.000653	0.00156	CcSEcCtD
Telaprevir—Urticaria—Methotrexate—lymphatic system cancer	0.000602	0.00144	CcSEcCtD
Telaprevir—Asthenia—Methotrexate—lymphatic system cancer	0.000543	0.0013	CcSEcCtD
Telaprevir—Pruritus—Methotrexate—lymphatic system cancer	0.000536	0.00128	CcSEcCtD
Telaprevir—Diarrhoea—Methotrexate—lymphatic system cancer	0.000518	0.00124	CcSEcCtD
Telaprevir—Dizziness—Methotrexate—lymphatic system cancer	0.000501	0.00119	CcSEcCtD
Telaprevir—Vomiting—Methotrexate—lymphatic system cancer	0.000482	0.00115	CcSEcCtD
Telaprevir—Rash—Methotrexate—lymphatic system cancer	0.000478	0.00114	CcSEcCtD
Telaprevir—Dermatitis—Methotrexate—lymphatic system cancer	0.000477	0.00114	CcSEcCtD
Telaprevir—Nausea—Methotrexate—lymphatic system cancer	0.00045	0.00107	CcSEcCtD
